Related Experiment Video
Updated: Jul 11, 2026
04:29
Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
Published on: January 7, 2019
[Other treatments for depressive patients]
Toshio Tamaoki1, Nobutaka Motohashi
1Department of Neuropsychiatry and Clinical Ethics, Interdisciplinary Graduate School of Medicine and Engineering, University of Yamanashi.
Nihon Rinsho. Japanese Journal of Clinical Medicine
|September 20, 2007
Summary
Electroconvulsive therapy (ECT) effectively treats depression when medication fails, but side effects like cognitive issues persist. Newer brain stimulation techniques are being explored to overcome ECT limitations.
Area of Science:
- Neuroscience
- Psychiatry
- Medical Technology
Context:
- Electroconvulsive therapy (ECT) is a primary treatment for severe depression unresponsive to pharmacotherapy.
- Meta-analyses confirm ECT's superiority over pharmacotherapy in acute depression treatment.
- Historical development of ECT includes modifications and brief-pulse stimulation to mitigate adverse effects.
Purpose:
- To review the efficacy and limitations of Electroconvulsive therapy (ECT) in treating depression.
- To explore alternative neuromodulation techniques addressing ECT's unresolved challenges.
- To highlight ongoing research into Transcranial magnetic stimulation (TMS), vagus nerve stimulation (VNS), and deep brain stimulation (DBS).
Summary:
- ECT remains a vital treatment for depression, particularly for medication-resistant cases.
- Despite improvements, ECT's cognitive side effects and non-response rates necessitate further research.
- Emerging therapies like TMS, VNS, and DBS show promise in overcoming ECT's shortcomings.
Impact:
- Provides a comprehensive overview of ECT's role and limitations in psychiatric care.
- Informs clinicians and researchers about the potential of novel brain stimulation therapies.
- Contributes to the advancement of depression treatment strategies for improved patient outcomes.
More Related Videos
Related Concept Videos
01:23Antidepressant Drugs: MAOIs and Other Agents
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
01:30Electroconvulsive Therapy
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early years,...
01:24Treatment Strategies for Psychological Disorders
Treatment approaches for psychological disorders fall into three main categories: psychological, biological, and sociocultural. Each approach targets different aspects of mental health, requiring varying levels of education and training.
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...
01:28Drug Therapy
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
01:28Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
01:25Antidepressant Drugs: Overview
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...